ADMA Biologics (ADMA) Earnings Date & Reports

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

ADMA is expected to report earnings to fall 68.11% to 14 cents per share on May 07

ADMA Biologics ADMA Stock Earnings Reports

Q1'25

Est.

$0.15

Q4'24

Beat

by $0.31

Q3'24

Beat

by $0.02

Q2'24

Beat

by $0.05

Q1'24

Beat

by $0.03

The last earnings report on March 03 showed earnings per share of 46 cents, beating the estimate of 15 cents. With 2.22M shares outstanding, the current market capitalization sits at 4.61B.

View a ticker or compare two or three

Compare

ADMA